McKesson Corporation (MCK) Análisis de acciones

Descripción de la empresa

McKesson Corporation operates as a pivotal distributor of healthcare services, executing its business model through four primary segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International operations. The company functions within the Healthcare sector and specifically the Medical Distribution industry, a position that underscores its critical role in the supply chain for pharmaceuticals and medical supplies. With a substantial market capitalization of $106.17B and annual revenue reaching $397.96B, McKesson employs a workforce of 43000 individuals across its global footprint. These valuation and revenue figures indicate that McKesson commands a massive scale, reflecting its established dominance and significant influence over the pricing and availability of essential medical products in the United States and international markets.

Salud financiera

The company reported a revenue of $397.96B for the trailing twelve months, generating a net income of $4.34B and an EBITDA of $5.93B. The substantial disparity between the total revenue and the net income reveals a cost structure characterized by high operating expenses, where thin profit margins are typical for a distribution business model. McKesson maintains a robust free cash flow of $9.16B, which provides significant financial flexibility to fund operational needs, invest in technology, or manage capital allocation without relying on external financing. The company's profitability is further detailed by a gross margin of 3.5%, an operating margin of 1.5%, and a profit margin of 1.1%, indicating that the business operates on very thin spreads where efficiency in logistics and purchasing is paramount to maintaining profitability. On the balance sheet, McKesson holds $2.96B in cash against $8.73B in debt, while the debt-to-equity ratio is listed as N/A, suggesting a specific capital structure where equity may not be the primary benchmark for leverage in this sector. The current ratio stands at 0.88, which indicates that the company's current assets do not fully cover its current liabilities, a common characteristic for distribution firms reliant on working capital cycles. Regarding return metrics, the Return on Assets is 4.3%, while the Return on Equity is N/A, revealing that the company generates returns relative to its asset base but does not utilize traditional equity metrics to measure performance in the same manner as leveraged firms.

Evaluación de valoración

McKesson's valuation metrics include a trailing P/E ratio of 24.82 and a forward P/E of 19.45, implying that the market expects earnings to grow significantly in the future to justify the higher current multiple. The price-to-book ratio is reported as -81.51, a figure that indicates the market values the company differently than its book value, often seen in asset-heavy or capital-intensive industries where book value is not the primary driver of equity price. Alternative valuation measures such as a price-to-sales ratio of 0.27 and an EV/EBITDA of 18.95 suggest that the stock is priced relative to its sales volume and earnings before interest, taxes, and depreciation, providing a broader view of value beyond traditional earnings multiples. In terms of trading range, the stock has a 52-week high of $999.00 and a 52-week low of $637.00, placing the current trading position within a wide band of volatility relative to these historical extremes. The beta value of 0.35 indicates that the stock exhibits low price volatility relative to the broader market, moving with significantly less sensitivity than the overall equity market.

Growth & Income

The company demonstrated a revenue growth of 11.4% year-over-year alongside an earnings growth of 38.0% year-over-year. The fact that earnings are growing at a rate of 38.0% while revenue grows at 11.4% implies that the company is improving its profitability per unit sold, likely through operational efficiencies or favorable pricing dynamics. As a payer of dividends, McKesson offers a yield of 0.4% with a payout ratio of 8.8%, indicating that the dividend is highly sustainable given the low portion of earnings distributed to shareholders. This conservative payout ratio allows the company to retain the majority of its earnings, which supports the high growth rate observed in the last year rather than focusing on immediate income distribution. The overall growth and income profile of McKesson is defined by rapid earnings expansion supported by a low but stable dividend yield that reflects its mature status in the healthcare distribution sector.